Abstract:Recently, a novel coronavirus (2019-nCoV) has emerged from Wuhan, China, causing symptoms in humans similar to those caused by severe acute respiratory syndrome coronavirus (SARS-CoV). Since the SARS-CoV outbreak in 2002, extensive structural analyses have revealed key atomic-level interactions between the SARS-CoV spike protein receptor-binding domain (RBD) and its host receptor angiotensin-converting enzyme 2 (ACE2), which regulate both the cross-species and human-to-human transmissions of SARS-CoV. Here, we analyzed the potential receptor usage by 2019-nCoV, based on the rich knowledge about SARS-CoV and the newly released sequence of 2019-nCoV. First, the sequence of 2019-nCoV RBD, including its receptor-binding motif (RBM) that directly contacts ACE2, is similar to that of SARS-CoV, strongly suggesting that 2019-nCoV uses ACE2 as its receptor. Second, several critical residues in 2019-nCoV RBM (particularly Gln493) provide favorable interactions with human ACE2, consistent with 2019-nCoV's capacity for human cell infection. Third, several other critical residues in 2019-nCoV RBM (particularly Asn501) are compatible with, but not ideal for, binding human ACE2, suggesting that 2019-nCoV has acquired some capacity for human-to-human transmission. Last, while phylogenetic analysis indicates a bat origin of 2019-nCoV, 2019-nCoV also potentially recognizes ACE2 from a diversity of animal species (except mice and rats), implicating these animal species as possible intermediate hosts or animal models for 2019-nCoV infections. These analyses provide insights into the receptor usage, cell entry, host cell infectivity and animal origin of 2019-nCoV and may help epidemic surveillance and preventive measures against 2019-nCoV. IMPORTANCE The recent emergence of Wuhan coronavirus (2019-nCoV) puts the world on alert. 2019-nCoV is reminiscent of the SARS-CoV outbreak in 2002 to 2003. Our decade-long structural studies on the receptor recognition by SARS-CoV have identified key interactions between SARS-CoV spike protein and its host receptor angiotensin-converting enzyme 2 (ACE2), which regulate both the cross-species and human-to-human transmissions of SARS-CoV. One of the goals of SARS-CoV research was to build an atomic-level iterative framework of virus-receptor interactions to facilitate epidemic surveillance, predict species-specific receptor usage, and identify potential animal hosts and animal models of viruses. Based on the sequence of 2019-nCoV spike protein, we apply this predictive framework to provide novel insights into the receptor usage and likely host range of 2019-nCoV. This study provides a robust test of this reiterative framework, providing the basic, translational, and public health research communities with predictive insights that may help study and battle this novel 2019-nCoV.

Updated Analysis to Reject the Laboratory-Engineering Hypothesis of SARS-CoV-2

Recombination between coronaviruses and synthetic RNAs and biorisk implications motivated by a SARS-CoV-2 FCS origin controversy

Tracing the origins of SARS-COV-2 in coronavirus phylogenies: a review

Tracing the origins of SARS-CoV-2 in coronavirus phylogenies

An open debate on SARS-CoV-2's proximal origin is long overdue

Emergence of crucial evidence catalyzing the origin tracing of SARS-CoV-2

The Emergence and Evolution of SARS-CoV-2

On the origin of SARS-CoV-2—The blind watchmaker argument

Evolutionary history, potential intermediate animal host, and cross‐species analyses of SARS‐CoV‐2

In-silico nucleotide and protein analyses of S-gene region in selected zoonotic coronaviruses reveal conserved domains and evolutionary emergence with trajectory course of viral entry from SARS-CoV2 genomic data

In silico comparison of spike protein-ACE2 binding affinities across species; significance for the possible origin of the SARS-CoV-2 virus

SARS-CoV-2: Origin, Intermediate Host and Allergenicity Features and Hypotheses

Design and Application of Biosafe Coronavirus Engineering Systems without Virulence

Genomic Feature Analysis of Betacoronavirus Provides Insights Into SARS and COVID-19 Pandemics

Genomic determinants of pathogenicity in SARS-CoV-2 and other human coronaviruses

The Origins of Severe Acute Respiratory Syndrome-Coronavirus-2

Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus

On the Origin and Continuing Evolution of SARS-CoV-2

Response to comments on "Cross‐species Transmission of the Newly Identified Coronavirus 2019‐nCoV” and “Codon bias analysis may be insufficient for identifying host(s) of a novel virus”

On the origin and evolution of SARS-CoV-2

Non-uniform aspects of the SARS-CoV-2 intraspecies evolution reopen question of its origin